Biocytogen27s_LOGO

Eucure Biopharma, a Subsidiary of Biocytogen, Announces Partnership with ISU ABXIS for the Development of Tri-specific Antibodies using YH003 Antibody Sequence

YH003 is an agonistic anti-CD40 IgG2 monoclonal antibody with best-in-class potential. YH003 in combination with PD-1 are being dosed in...

ORUM2BLOGO2B-2BPNG

Orum Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of ORM-5029 in Development to Treat HER2-Expressing Advanced Solid Tumors

ORM-5029 is a first-in-class drug candidate designed to selectively deliver catalytic GSPT1 protein degraders to HER2-expressing tumor cells via antibody...

generic_link

Lightnet Group Partners with Raffles Family Office to Expand Payment Ecosystem to Revo – Asia’s First Digital Asset-Based Multi-Family Office Platform

SINGAPORE - Media OutReach - 1 November 2022 - Singapore-based Lightnet Group ("Lightnet") announced today the completion of Raffles Family...

logo-162

Cell Reprogramming Market Share, Size, Trends, Industry Analysis Report, By Technology, By Application, By End-Use, By Region, Segment Forecast, 2022 – 2030 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Cell Reprogramming Market Share, Size, Trends, Industry Analysis Report, By Technology, By Application, By End-Use, By Region, Segment...

logo-159

Global Architectural White Marble Market Insights and Forecasts, 2017-2021 & 2022-2027: Competitive Developments, Strategies, Mergers and Acquisitions and New Product Developments – ResearchAndMarkets.com